• Quantum Biopharma granted 572,500 stock options to directors, officers, employees, consultants under its omnibus equity incentive plan.
• Options carry an exercise price of C$ 4.8; term runs five years, expiring Aug. 20, 2031.
• Immediate vesting applies to 172,500 options; remaining 400,000 options vest based on performance conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.